Inhibition of the Redox Function of APE1/Ref-1 in Myeloid Leukemia Cell Lines Results in a Hypersensitive Response to Retinoic Acid-induced Differentiation and Apoptosis

Por Fishel, Melissa L., Colvin, E. Scott, Luo, Meihua, Kelley, Mark R., Robertson, Kent A.
Publicado em 2010

CSK Controls Retinoic Acid Receptor (RAR) Signaling: a RAR-c-SRC Signaling Axis Is Required for Neuritogenic Differentiation

Por Dey, Nandini, De, Pradip K., Wang, Mu, Zhang, Hongying, Dobrota, Erika A., Robertson, Kent A., Durden, Donald L.
Publicado em 2007

The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression

Por Guo, Ying, Costa, Robert, Ramsey, Heather, Starnes, Trevor, Vance, Gail, Robertson, Kent, Kelley, Mark, Reinbold, Rolland, Scholer, Hans, Hromas, Robert
Publicado em 2002

FANCA safeguards interphase and mitosis during hematopoiesis in vivo

Por Abdul-Sater, Zahi, Cerabona, Donna, Sierra Potchanant, Elizabeth, Sun, Zejin, Enzor, Rikki, He, Ying, Robertson, Kent, Goebel, W. Scott, Nalepa, Grzegorz
Publicado no Exp Hematol (2015)

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation

Por Akil, Ayman, Zhang, Qing, Mumaw, Christen L, Raiker, Nisha, Yu, Jeffrey, de Mendizabal, Nieves Velez, Haneline, Laura S., Robertson, Kent A., Skiles, Jodi, Diaz-Ricart, Maribel, Carreras, Enric, Renbarger, Jamie, Hanash, Samir, Bies, Robert R., Paczesny, Sophie
Publicado no Biol Blood Marrow Transplant (2015)

Nf1-Dependent Tumors Require a Microenvironment Containing Nf1(+/−)- and c-kit-Dependent Bone Marrow

Por Yang, Feng-Chun, Ingram, David A., Chen, Shi, Zhu, Yuan, Yuan, Jin, Li, Xiaohong, Yang, Xianlin, Knowles, Scott, Horn, Whitney, Li, Yan, Zhang, Shaobo, Yang, Yanzhu, Vakili, Saeed T., Yu, Menggang, Burns, Dennis, Robertson, Kent, Hutchins, Gary, Parada, Luis F., Clapp, D. Wade
Publicado em 2008

Recommendations for imaging tumor response in neurofibromatosis clinical trials

Por Dombi, Eva, Ardern-Holmes, Simone L., Babovic-Vuksanovic, Dusica, Barker, Fred G., Connor, Steve, Evans, D. Gareth, Fisher, Michael J., Goutagny, Stephane, Harris, Gordon J., Jaramillo, Diego, Karajannis, Matthias A., Korf, Bruce R., Mautner, Victor, Plotkin, Scott R., Poussaint, Tina Y., Robertson, Kent, Shih, Chie-Schin, Widemann, Brigitte C.
Publicado em 2013

Pilot Phase II Trial of Imatinib Mesylate in Neurofibromatosis Type 1 patients with Plexiform Neurofibromas

Por Robertson, Kent A., Nalepa, Grzegorz, Yang, Feng-Chun, Bowers, Daniel C., Ho, Chang Y., Hutchins, Gary D., Croop, James M., Vik, Terry A., Denne, Scott C., Parada, Luis F., Hingtgen, Cynthia M., Walsh, Laurence E., Yu, Menggang, Pradhan, Kamnesh R., Edwards-Brown, Mary K., Cohen, Mervyn D., Fletcher, James W., Travers, Jeffrey B., Staser, Karl W., Lee, Melissa W., Sherman, Marcie R., Davis, Cynthia J., Miller, Lucy C., Ingram, David A., Clapp, D. Wade
Publicado no Lancet Oncol (2012)